MarketFriction

Ajooni Biotech Ltd

NSE AJOONI · Animal Feed
₹3.10 -0.96%
NSE close2026-10-01
52 week range3.02 - 5.50
Market cap₹54.1 Cr.
P/E13.7
Price band 20% Delivery 60.3%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales19.4820.0519.5825.6625.7234.0329.2731.2731.7458.7560.6263.49
Expenses18.8520.7017.9924.7024.9533.1028.2630.5630.2455.7259.6161.82
Operating Profit0.63-0.651.590.960.770.931.010.711.503.031.011.67
OPM %3.23%-3.24%8.12%3.74%2.99%2.73%3.45%2.27%4.73%5.16%1.67%2.63%
Other Income0.291.570.260.040.310.391.340.650.150.321.300.27
Interest0.190.120.110.150.060.070.060.080.170.180.290.48
Depreciation0.210.210.240.220.230.240.380.250.250.810.900.80
Profit before tax0.520.591.500.630.791.011.911.031.232.361.120.66
Tax %23.08%23.73%38.67%25.40%22.78%27.72%19.37%24.27%24.39%30.08%15.18%34.85%
Net Profit0.400.440.910.470.620.731.540.780.931.650.950.43
EPS in Rs0.020.030.050.030.040.040.090.050.050.100.060.02
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales132942404051747480115182215
Expenses132841393949717278111175207
Operating Profit011112332467
OPM %1.7%2.4%2.2%1.7%3.1%3.2%4.2%3.7%2.8%3.2%3.4%3.4%
Other Income000000002222
Interest000001101011
Depreciation000001111123
Profit before tax000000123465
Tax %29%28%20%15%29%26%28%28%28%22%25%
Net Profit000000112344
EPS in Rs0.180.360.030.030.020.020.050.060.120.200.250.23
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth30%29%35%78%
Compounded Profit Growth44%60%51%8%
Stock Price CAGR%-25%-8%-41%
Return on Equity4%4%4%4%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.240.240.33668101018183434
Reserves0015676624255457
Borrowings0115557552218
Other Liabilities111141267123511
Total Liabilities22131918232829594895120
Fixed Assets001112566101126
CWIP000000000100
Investments006643114232
Other Assets126121318222248348092
Total Assets22131918232829594895120
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0-1-3-3-5-414-623-32-6
Cash from Investing Activity-0-0-2-010-3-2-16814-16
Cash from Financing Activity0158-132-222-42515
Net Cash Flow0-005-5-10-00276-6
Free Cash Flow-0-1-3-3-5-6-22-817-33-23
CFO/OP169%-257%-427%-284%-706%-353%71%125%-185%1,047%-845%-92%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days40331725441159868101595236
Inventory Days221463195134463439809097
Days Payable6627799122046395681322
Cash Conversion Cycle-42013584129986383131129111
Working Capital Days59-29-18410577589413215893
ROCE %28%18%37%10%4%4%5%9%6%8%5%6%
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Aug 2026
Promoters26.44%26.44%26.89%26.89%26.89%26.89%26.89%26.89%26.89%26.89%26.89%30.53%
FIIs0.00%0.00%0.00%0.29%0.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public73.56%73.56%73.11%72.82%72.92%73.11%73.11%73.11%73.11%73.11%73.11%69.47%
No. of Shareholders30,93341,05351,22463,90664,10263,96863,30564,30562,69961,77960,67560,170

Fundamentals

Market Cap₹ 54.1 Cr.
Current Price₹ 3.14
Stock P/E13.7
Book Value₹ 5.29
ROCE6.11 %
ROE4.28 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)78%
Compounded Profit Growth (TTM)8%
Standalone figures.
Valuation
Market capRs 53 Cr
Enterprise valueRs 71 Cr
P/E (TTM)13.48x
Price to book0.59x
Price to sales0.25x
EV / EBITDA7.65x
EV / EBIT10.90x
EV / sales0.33x
Earnings yield7.42%
P/E, 3-year average21.69x
P/B, 3-year average0.96x
P/E, 5-year average21.60x
P/B, 5-year average0.92x
Profitability
Operating margin (excl. other income)3.44%
Operating margin (incl. other income)4.77%
EBITDA margin4.31%
Pre-tax margin2.50%
Net profit margin1.85%
Net margin, latest quarter0.68%
ROE4.82%
ROCE6.49%
ROA4.01%
ROE, 3-year average5.03%
ROCE, 3-year average7.05%
ROA, 3-year average4.27%
ROE, 5-year average5.10%
ROCE, 5-year average7.24%
ROA, 5-year average3.81%
ROIC (approx.)4.50%
Tax rate24.78%
Other income / net worth2.65%
Growth
Sales growth (latest year)58.63%
Profit growth (latest year)28.19%
Sales CAGR, 3 years34.62%
Sales CAGR, 5 years29.02%
Profit CAGR, 3 years56.83%
Profit CAGR, 5 years63.48%
Sales growth QoQ4.73%
Profit growth QoQ-54.74%
Sales growth YoY (latest quarter)103.04%
Profit growth YoY (latest quarter)-44.87%
Per share
EPS (TTM)Rs 0.23
EPS (latest year)Rs 0.25
EPS (latest quarter)Rs 0.03
EPS, 3-year averageRs 0.23
EPS, 5-year averageRs 0.37
Book value per shareRs 5.29
Sales per shareRs 12.46
Cash flow per shareRs -0.33
Free cash flow per shareRs -1.34
Efficiency
Asset turnover1.51x
Fixed asset turnover6.93x
Inventory turnover3.86x
Inventory days94 days
Debtor days36 days
Debtors turnover10.19x
Creditor days22 days
Cash conversion cycle111 days
Working capital days93 days
Leverage
Total debtRs 18 Cr
Cash and bankRs 0 Cr
Net debtRs 17 Cr
Debt to equity0.19x
Net debt / EBITDA1.87x
Interest coverage5.79x
Owners' fund to total sources75.76%
Debt to assets14.76%
Cash flow
Cash from Operating Activity (latest year)Rs -6 Cr
Cash from Investing Activity (latest year)Rs -16 Cr
Cash from Financing Activity (latest year)Rs 15 Cr
Net Cash Flow (latest year)Rs -6 Cr
Free cash flow (latest year)Rs -23 Cr
FCFE (approx.: FCF + change in debt)Rs -7 Cr
Cash from ops / profit, 5 years-1.55x
Statement figures
Net sales (TTM)Rs 215 Cr
Net sales (latest year)Rs 182 Cr
Sales (latest quarter)Rs 63 Cr
Operating profit excl. other income (latest year)Rs 6 Cr
Operating profit (latest quarter)Rs 2 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 9 Cr
PBDT (TTM)Rs 8 Cr
Profit before tax (TTM)Rs 5 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 4 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 3 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 152 Cr
Total expenditure (latest year)Rs 175 Cr
Total income (latest year)Rs 184 Cr
Share capitalRs 34 Cr
ReservesRs 57 Cr
Shareholders' fundsRs 91 Cr
Total assetsRs 120 Cr
Net blockRs 26 Cr
InvestmentsRs 2 Cr
ReceivablesRs 18 Cr
InventoryRs 39 Cr
Other liabilitiesRs 11 Cr
Shares outstanding (crore)17.22
Ownership
Promoter holding30.53% (+3.64 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 13.5 is the lowest in its own 7.6-year history (median 81.2, low 13.5, high 399.9).
P/B 0.59 is the lowest in 8.8 years (median 3.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodAJOONINifty 50Difference
1 week-2.5%-2.8% +0.3 pts
1 month-17.3%-6.8% -10.5 pts
3 months-18.6%-7.6% -11.0 pts
6 months-19.3%+0.4% -19.7 pts
1 year-42.6%-9.9% -32.7 pts
2 years-64.0%-13.6% -50.5 pts
3 years-31.1%+14.2% -45.3 pts
5 years-73.4%+27.9% -101.3 pts

Red flags

F-score 5 of 8
explainWeak cash conversion Cash from operations was -150% of net profit over the last 3 years
lookProfit leans on other income Other income was 42% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹63 Cr +103.0% vs Jun 2025. Net profit ₹0 Cr -44.9%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Godrej Agrovet Ltd12,15525.919.2 %
Avanti Feeds Ltd10,18418.924.4 %
Mukka Proteins Ltd78311.311.6 %
KSE Ltd57012.433.6 %
Shivam Chemicals Ltd21235.516.6 %
Mayank Cattle Food Ltd11419.015.8 %
Narmada Agrobase Ltd9727.18.95 %
No bulk or block deals on record.
Ex-dateActionFactor
2024-09-10Annual General Meeting
2024-05-07Rights 1:1 @ Premium Rs 3/-
2023-08-29Annual General Meeting
2022-11-25Rights 29:30 @ Premium Rs 4/-
2022-10-07Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share0.2000
2022-09-13Annual General Meeting
2021-09-17 Annual General Meeting
DateTypeWhat it says
2026-08-14Board meeting outcomeAjooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-14Board meeting outcomeAjooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-12AllotmentAllotment of 9000000 securities pursuant to Preferential Issue at its meeting held on August 12, 2026
2026-07-31Increase in Authorised CapitIncrease in Authorised Capital
2026-07-31Issue of SecuritiesIssue of Securities
2026-07-31RetirementRetirement
2026-07-31Amendment to AOA/MOAThe Amendment to AOA/MOA of the company.
2026-07-31Shareholder meetingVoting results.
2026-07-29Shareholder meetingProceedings of Annual General Meeting held on July 29, 2026
2026-07-14UpdatesConfirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Q...
2026-07-14UpdatesUndertaking of functional website.
2026-07-01Shareholder meetingNotice of Annual General Meeting to be held on July 29, 2026
2026-06-29UpdatesIntimation of Book Closure for the purpose of Annual General Meeting.
2026-06-29Amendment to AOA/MOAThe Amendment to AOA/MOA of the company.
2026-06-29Board meeting outcomeOutcome of Board Meeting held on Jun 29, 2026.
2026-05-28Board meeting outcomeAjooni Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-05-22Disclosure under SEBI TakeovAjooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa...
2026-05-22Disclosure under SEBI TakeovAjooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa...
2026-05-21Board meeting outcomeOutcome of Board Meeting held on May 21, 2026.
2026-05-21General UpdatesGeneral Updates
2026-05-06Disclosure under SEBI TakeovAjooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa...
2026-04-10UpdatesUndertaking of functional website.
2026-04-10UpdatesConfirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Q...
2026-02-09Press ReleaseA press release dated February 09, 2026, titled "Ajooni Biotech Receives Prestigious Significant Biggest ever Order worth Rs,.47.52 crores ".
2026-02-09Press ReleaseA press release dated February 09, 2026, titled "Ajooni Biotech Receives Prestigious Significant Biggest ever Order worth ₹47.52 crores ".
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Ajooni Biotech Ltd?

Ajooni Biotech Ltd (AJOONI) has a market capitalisation of Rs 54.1 Cr. at the 2026-10-01 close.

What is the P/E ratio of Ajooni Biotech Ltd?

Ajooni Biotech Ltd trades at a P/E of 13.7 on trailing twelve-month profit, at the 2026-10-01 close.

What were Ajooni Biotech Ltd's latest quarterly results?

In the Jun 2026 quarter, Ajooni Biotech Ltd sales was Rs 63 Cr (+103.0% vs Jun 2025) and net profit was Rs 0 Cr.

What is the 52-week high and low of Ajooni Biotech Ltd?

The 52-week high is Rs 5.50 and the 52-week low is Rs 3.02.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03